Jagsonpal Pharmaceuticals has informed that Centrum Capital (Manager to the Offer) has submitted a copy of Letter of Offer to the eligible public shareholders of Jagsonpal Pharmaceuticals (Target Company).
The above information is a part of company’s filings submitted to BSE.